In this issue:
LEAP 2: intervention for overweight, obese children
Mild gestational diabetes treatment
Rituximab and β-cell function
Intensive glucose control & macrovascular outcomes
3-year efficacy of complex insulin regimens
Neighbourhood physical activity/healthy foods and type 2 diabetes
Coffee/tea and type 2 diabetes risk
Malignancies and insulin glargine
Insulin detemir and malignancy risk
Cancer risk in type 2 diabetes
Please login below to download this issue (PDF)